Exact Mass: 317.1448

Exact Mass Matches: 317.1448

Found 91 metabolites which its exact mass value is equals to given mass value 317.1448, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Hydroxyprolyl-Tryptophan

2-{[hydroxy(4-hydroxypyrrolidin-2-yl)methylidene]amino}-3-(1H-indol-3-yl)propanoate

C16H19N3O4 (317.1375)


Hydroxyprolyl-Tryptophan is a dipeptide composed of hydroxyproline and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Tryptophylhydroxyproline

(2S,4R)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]-4-hydroxypyrrolidine-2-carboxylic acid

C16H19N3O4 (317.1375)


​Tryptophylhydroxyproline is a dipeptide composed of tryptophan and hydroxyproline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

2-[5-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxy-2-pyrrolylidene]indole

2-((2Z)-2-((3,5-Dimethyl-1H-pyrrol-2-yl)methylene)-3-methoxy-2H-pyrrol-5-yl)-1H-indole methanesulfonate (1:1)

C20H19N3O (317.1528)


   

Puquitinib

N6-cyclopropyl-N2-(quinolin-6-yl)-7H-purine-2,6-diamine

C17H15N7 (317.1389)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

   
   

Maybridge1_007743

Maybridge1_007743

C19H24ClNO (317.1546)


   

parazoanthine A

parazoanthine A

C15H19N5O3 (317.1488)


   
   

(S)-Cyclo(arginyldehydrotyrosyl)|cyclo-(L-Arg-dehydrotyrosine)

(S)-Cyclo(arginyldehydrotyrosyl)|cyclo-(L-Arg-dehydrotyrosine)

C15H19N5O3 (317.1488)


   
   
   
   
   
   

1,2-Benzenediol, 4-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-, (3S-trans)-

1,2-Benzenediol, 4-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-, (3S-trans)-

C18H20FNO3 (317.1427)


   
   
   
   
   
   
   
   
   
   
   
   

Hpro-TRP

1-[2-amino-3-(1H-indol-3-yl)propanoyl]-4-hydroxypyrrolidine-2-carboxylic acid

C16H19N3O4 (317.1375)


   

TRP-HPro

2-[(4-hydroxypyrrolidin-2-yl)formamido]-3-(1H-indol-3-yl)propanoic acid

C16H19N3O4 (317.1375)


   

4-CHLORO-5-METHYL-N-(3-(4-METHYLPIPERAZIN-1-YL)PHENYL)PYRIMIDIN-2-AMINE

4-CHLORO-5-METHYL-N-(3-(4-METHYLPIPERAZIN-1-YL)PHENYL)PYRIMIDIN-2-AMINE

C16H20ClN5 (317.1407)


   

6-Benzyl-2-phenyl-5,6,7,8-tetrahydro-3H-pyrido[4,3-d]pyrimidin-4-one

6-Benzyl-2-phenyl-5,6,7,8-tetrahydro-3H-pyrido[4,3-d]pyrimidin-4-one

C20H19N3O (317.1528)


   

6-Ethoxy-5-(trifluoromethyl)pyridine-3-boronic acid pinacol ester

6-Ethoxy-5-(trifluoromethyl)pyridine-3-boronic acid pinacol ester

C14H19BF3NO3 (317.141)


   

Diphenylpyraline hydrochloride

Diphenylpyraline (hydrochloride)

C19H24ClNO (317.1546)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Diphenylpyraline hydrochloride is a potent histamine H1?receptor antagonist. Diphenylpyraline hydrochloride acts as an orally active antihistamine agent?with antimuscarinic and antiallergic effects. Diphenylpyraline hydrochloride can be used for the relief of allergic conditions including rhinitis and hay fever, and in pruritic skin disorders in vivo.[1]

   

tert-butyl 3-(4-fluorophenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxylate

tert-butyl 3-(4-fluorophenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxylate

C17H20FN3O2 (317.1539)


   

3-(2-((tert-Butyldimethylsilyloxy)methyl)furo[3,2-b]pyridin-6-yl)prop-2-yn-1-ol

3-(2-((tert-Butyldimethylsilyloxy)methyl)furo[3,2-b]pyridin-6-yl)prop-2-yn-1-ol

C17H23NO3Si (317.1447)


   

2H-Pyrrol-2-one, 4-acetyl-5-cyclohexyl-1-(4-fluorophenyl)-1,5-dihydro-3-hydroxy-, (5R)-

2H-Pyrrol-2-one, 4-acetyl-5-cyclohexyl-1-(4-fluorophenyl)-1,5-dihydro-3-hydroxy-, (5R)-

C18H20FNO3 (317.1427)


   

2H-Pyrrol-2-one, 4-acetyl-5-cyclohexyl-1-(3-fluorophenyl)-1,5-dihydro-3-hydroxy-

2H-Pyrrol-2-one, 4-acetyl-5-cyclohexyl-1-(3-fluorophenyl)-1,5-dihydro-3-hydroxy-

C18H20FNO3 (317.1427)


   

dibenzyl diethylphosphoramidite

dibenzyl diethylphosphoramidite

C18H24NO2P (317.1545)


   

Methanone, (3-ethyl-5-methyl-4-isoxazolyl)[4-(2-fluorophenyl)-1-piperazinyl]

Methanone, (3-ethyl-5-methyl-4-isoxazolyl)[4-(2-fluorophenyl)-1-piperazinyl]

C17H20FN3O2 (317.1539)


   

Methanone, (3-ethyl-5-methyl-4-isoxazolyl)[4-(4-fluorophenyl)-1-piperazinyl]

Methanone, (3-ethyl-5-methyl-4-isoxazolyl)[4-(4-fluorophenyl)-1-piperazinyl]

C17H20FN3O2 (317.1539)


   

2H-Pyrrol-2-one, 4-acetyl-5-cyclohexyl-1-(2-fluorophenyl)-1,5-dihydro-3-hydroxy-

2H-Pyrrol-2-one, 4-acetyl-5-cyclohexyl-1-(2-fluorophenyl)-1,5-dihydro-3-hydroxy-

C18H20FNO3 (317.1427)


   

2-(3,5-DIMETHYL-BIPHENYL-3-YLAMINO)-BENZOIC ACID

2-(3,5-DIMETHYL-BIPHENYL-3-YLAMINO)-BENZOIC ACID

C21H19NO2 (317.1416)


   

UNII:4EMP7E490R

UNII:4EMP7E490R

C19H24ClNO (317.1546)


   

(S)-Decarboxyl ofloxacin

(S)-Decarboxyl ofloxacin

C17H20FN3O2 (317.1539)


   

N-Tritylglycine

N-Tritylglycine

C21H19NO2 (317.1416)


   

ETHYL 3-((4-ACETAMIDO-3-ETHOXYPHENYL)AMINO)-2-CYANOACRYLATE

ETHYL 3-((4-ACETAMIDO-3-ETHOXYPHENYL)AMINO)-2-CYANOACRYLATE

C16H19N3O4 (317.1375)


   

N-Benzyl-2-methoxy-N-phenylbenzamide

N-Benzyl-2-methoxy-N-phenylbenzamide

C21H19NO2 (317.1416)


   

2-ethoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine

2-ethoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine

C14H19BF3NO3 (317.141)


   

N-(2-HYDROXY-2,2-DIPHENYLETHYL)BENZENECARBOXAMIDE

N-(2-HYDROXY-2,2-DIPHENYLETHYL)BENZENECARBOXAMIDE

C21H19NO2 (317.1416)


   

Iron(III) 2-ethylhexano-isopropoxide, 10 w/v in isopropanol

Iron(III) 2-ethylhexano-isopropoxide, 10 w/v in isopropanol

C14H29FeO4 (317.1415)


   

N-Benzyl-4-(benzylamino)picolinamide

N-Benzyl-4-(benzylamino)picolinamide

C20H19N3O (317.1528)


   

obatoclax

(2E)-2-[(5E)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole

C20H19N3O (317.1528)


C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent > C192025 - Bcl-2 Family Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C159200 - BCL-2 Inhibitor D004791 - Enzyme Inhibitors

   

AE-37 hydrochloride

AE-37 hydrochloride

C19H24ClNO (317.1546)


C26170 - Protective Agent > C1509 - Neuroprotective Agent

   

Mecloxamine

Mecloxamine

C19H24ClNO (317.1546)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

O-Benzoyl-N,N-dibenzylhydroxylamine

O-Benzoyl-N,N-dibenzylhydroxylamine

C21H19NO2 (317.1416)


   

5-Methyl-3-[2-(4-morpholinyl)-2-oxoethyl]-5-phenylimidazolidine-2,4-dione

5-Methyl-3-[2-(4-morpholinyl)-2-oxoethyl]-5-phenylimidazolidine-2,4-dione

C16H19N3O4 (317.1375)


   
   

L-methionyl-L-prolyl-L-alanine tripeptide

L-methionyl-L-prolyl-L-alanine tripeptide

C13H23N3O4S (317.1409)


   

Tryptophyl-hydroxyproline

Tryptophyl-hydroxyproline

C16H19N3O4 (317.1375)


   

(2Z)-2-[(5E)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole

(2Z)-2-[(5E)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole

C20H19N3O (317.1528)


   

1,2-Benzenediol, 4-(((3S,4R)-4-(4-fluorophenyl)-3-piperidinyl)methoxy)-

1,2-Benzenediol, 4-(((3S,4R)-4-(4-fluorophenyl)-3-piperidinyl)methoxy)-

C18H20FNO3 (317.1427)


   

3,5-Diacetyl-1,4-diphenyl-1,4-dihydropyridine

3,5-Diacetyl-1,4-diphenyl-1,4-dihydropyridine

C21H19NO2 (317.1416)


   

5-(3-hydroxyphenyl)-N-[2-(4-morpholinyl)ethyl]-3-isoxazolecarboxamide

5-(3-hydroxyphenyl)-N-[2-(4-morpholinyl)ethyl]-3-isoxazolecarboxamide

C16H19N3O4 (317.1375)


   

N-(4-nitrophenyl)-9-oxobicyclo[3.3.1]nonane-3-carbohydrazide

N-(4-nitrophenyl)-9-oxobicyclo[3.3.1]nonane-3-carbohydrazide

C16H19N3O4 (317.1375)


   

3-[5-(4-Fluorophenyl)-1-(2-oxolanylmethyl)-2-pyrrolyl]propanoic acid

3-[5-(4-Fluorophenyl)-1-(2-oxolanylmethyl)-2-pyrrolyl]propanoic acid

C18H20FNO3 (317.1427)


   

(2Z,10Z)-3-hydroxy-5,17-dioxo-4,5-secoestra-2,10-diene-3-oate

(2Z,10Z)-3-hydroxy-5,17-dioxo-4,5-secoestra-2,10-diene-3-oate

C18H21O5- (317.1389)


A steroid acid anion that is the conjugate base of (2Z,10Z)-3-hydroxy-5,17-dioxo-4,5-secoestra-2,10-diene-3-oic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3. A meta-cleavage metabolite in the estrogen degradation pathway.

   
   
   
   
   
   

4-Benzhydryloxy-1-methylpiperidin-1-ium;chloride

4-Benzhydryloxy-1-methylpiperidin-1-ium;chloride

C19H24ClNO (317.1546)


   

11-beta-Hydroxysaxitoxin

11-beta-Hydroxysaxitoxin

C10H19N7O5+2 (317.1448)


   
   
   
   
   
   
   

2-Butoxy-4-quinolinecarboxylic acid trimethylsilyl ester

2-Butoxy-4-quinolinecarboxylic acid trimethylsilyl ester

C17H23NO3Si (317.1447)


   

Hydroxyprolyl-Tryptophan

Hydroxyprolyl-Tryptophan

C16H19N3O4 (317.1375)


   

8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one

8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one

C20H19N3O (317.1528)


   

n-{3-[(4s)-2-hydroxy-1-[(1e)-2-(4-hydroxyphenyl)ethenyl]-5-oxo-4h-imidazol-4-yl]propyl}guanidine

n-{3-[(4s)-2-hydroxy-1-[(1e)-2-(4-hydroxyphenyl)ethenyl]-5-oxo-4h-imidazol-4-yl]propyl}guanidine

C15H19N5O3 (317.1488)


   

n-(3-{2-hydroxy-1-[(1e)-2-(4-hydroxyphenyl)ethenyl]-5-oxo-4h-imidazol-4-yl}propyl)guanidine

n-(3-{2-hydroxy-1-[(1e)-2-(4-hydroxyphenyl)ethenyl]-5-oxo-4h-imidazol-4-yl}propyl)guanidine

C15H19N5O3 (317.1488)


   

n-(3-{2-hydroxy-1-[2-(4-hydroxyphenyl)ethenyl]-5-oxo-4h-imidazol-4-yl}propyl)guanidine

n-(3-{2-hydroxy-1-[2-(4-hydroxyphenyl)ethenyl]-5-oxo-4h-imidazol-4-yl}propyl)guanidine

C15H19N5O3 (317.1488)


   

(2r,5r)-2-(1h-indol-3-ylmethyl)-5-isopropylpyrazine-2,3,5,6-tetrol

(2r,5r)-2-(1h-indol-3-ylmethyl)-5-isopropylpyrazine-2,3,5,6-tetrol

C16H19N3O4 (317.1375)


   

2-(1h-indol-3-ylmethyl)-5-isopropylpyrazine-2,3,5,6-tetrol

2-(1h-indol-3-ylmethyl)-5-isopropylpyrazine-2,3,5,6-tetrol

C16H19N3O4 (317.1375)


   

5-carbamimidamido-2-{[hydroxy(1h-indol-3-yl)methylidene]amino}pentanoic acid

5-carbamimidamido-2-{[hydroxy(1h-indol-3-yl)methylidene]amino}pentanoic acid

C15H19N5O3 (317.1488)


   

(7s,8s)-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one

(7s,8s)-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one

C20H19N3O (317.1528)


   

(2r)-5-carbamimidamido-2-{[hydroxy(1h-indol-3-yl)methylidene]amino}pentanoic acid

(2r)-5-carbamimidamido-2-{[hydroxy(1h-indol-3-yl)methylidene]amino}pentanoic acid

C15H19N5O3 (317.1488)